NASDAQ$CME

CME Group · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

CME Group's financial performance reflected growth in trading volume and strategic product innovation.

CME Group reported a revenue of $1.2 billion and an operating income of $675 million for Q2 2021. The average daily volume grew by 5%, driven by increases in Interest Rates, Agricultural, and Options markets. The company also introduced innovative new products, including micro-sized contracts and ESG-focused futures contracts.

  • Revenue reached $1.2 billion, and operating income was $675 million.
  • Average daily volume increased by 5% year-over-year.
  • Growth was driven by double-digit increases in Interest Rates, Agricultural, and Options markets.
  • Introduced new micro-sized contracts and ESG-focused futures contracts.

Headline financials

Total Revenue

$1.18B

Previous: $1.18B-0.3%
EPS (adj)

$1.64

Previous: $1.63+0.6%
Average Daily Volume

18.4M

Previous: 17.6M+4.8%
Average Rate Per Contract

$0.69

Previous: $0.73-4.9%
Capital Expenditures

-$68.2M

Previous: -$79.2M+13.9%
Free Cash Flow

$442M

Previous: $424M+4.2%
Net Income

$510M

Previous: $503M+1.4%
Operating Income

$675M

Previous: $638M+5.8%
Gross Profit

$1.18B

Previous: $1.18B-0.3%
Cash & Equivalents

$1.08B

Previous: $1.41B-23.1%
Total Assets

$179B

Previous: $117B+52.5%
Stock-Based Comp

$19.4M

Previous: $22.4M-13.4%

Revenue & EPS history

CME Group · Revenue · Quarterly

$1.18B

Q2 2021-0.3%vs Q2 2020
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

CME Group · $1.18B total across 3 segments · Q2 2021

  • Clearing and transaction fees
    $930M-1.1%
  • Market data and information services
    $145M+7.8%
  • Other
    $104M-3.1%

Forward guidance

CME Group will continue to support clients’ evolving trading needs through additional product innovation and the upcoming launch of our joint venture company to provide post-trade services for OTC markets.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-0.1%

Avg return

Earnings day

-0.5%

Avg return

5 days after

+1.9%

Avg return

30 days after

45%

33 / 73 earnings

Positive

+5.8%

Q1 2022

Best reaction

-6.8%

Q3 2011

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.7%-0.9%+2.4%
Q4 2025-0.3%+4.8%+8.2%
Q3 2025-0.3%+0.9%+1.7%
Q2 2025+0.3%-0.9%-4.2%
Q1 2025-1.5%+0.9%+7.0%
Q4 2024+3.0%+1.5%+7.0%
Q3 2024+1.6%+0.9%+1.3%
Q2 2024+1.0%+0.7%+4.9%
Q1 2024-2.0%-3.3%-0.9%
Q4 2023+1.7%+2.3%+4.9%
Q3 2023+0.6%-1.4%+1.4%
Q2 2023+3.9%+4.0%+6.3%
Q1 2023-1.8%-0.6%-5.9%
Q4 2022+2.9%+4.2%-1.8%
Q3 2022-1.7%-1.4%-0.5%
Q2 2022-2.1%-3.9%-3.6%
Q1 2022+5.8%+1.6%-6.3%
Q4 2021+1.1%-0.9%-6.4%
Q3 2021-0.4%-0.4%+1.3%
Q2 2021+1.3%-0.2%-5.7%
Q1 2021-0.5%-0.5%+6.8%
Q4 2020-4.8%-4.0%+8.9%
Q3 2020-5.9%-4.5%+9.6%
Q2 2020-1.7%-1.8%+6.6%
Q1 2020-3.3%-6.4%-0.9%
Q4 2019-1.6%+0.7%-14.0%
Q3 2019+2.4%-2.0%+0.9%
Q2 2019+1.7%+2.3%+10.1%
Q1 2019-3.4%-0.4%+7.4%
Q4 2018-2.8%-3.4%-5.7%
Q3 2018-1.3%+0.8%+4.5%
Q2 2018-2.4%-6.1%-0.1%
Q1 2018-2.3%-2.8%-0.9%
Q4 2017+3.7%+2.7%+8.3%
Q3 2017+2.8%+2.5%+6.0%
Q2 2017+1.3%+2.6%+2.6%
Q1 2017-3.2%-2.3%-1.7%
Q4 2016-0.8%-1.8%+2.6%
Q3 2016-2.8%-3.1%+9.7%
Q2 2016-0.5%+0.6%+3.1%
Q1 2016-2.7%
Q4 2015+4.5%
Q3 2015-1.5%
Q2 2015-1.0%
Q1 2015+1.8%
Q4 2014+5.6%
Q3 2014+2.4%
Q2 2014-2.2%
Q1 2014-1.2%
Q4 2013+0.5%
Q3 2013-1.4%
Q2 2013-2.4%
Q1 2013+0.8%
Q4 2012-2.7%
Q3 2012-2.0%
Q2 2012+2.4%
Q1 2012-1.7%
Q4 2011-0.1%
Q2 2011-0.1%
Q3 2011-6.8%
Q1 2011+0.7%
Q4 2010-2.2%
Q2 2010-2.2%
Q3 2010-0.4%
Q1 2009+3.6%
Q1 2010+1.1%
Q2 2009+1.9%
Q4 2007+1.9%
Q4 2009+1.9%
Q3 2008+2.5%
Q3 2009+2.5%
Q2 2008+0.4%
Q4 2008+0.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro